Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Johnson and Johnson
McKesson
Boehringer Ingelheim
Baxter
Deloitte
US Department of Justice
Citi
Harvard Business School

Generated: December 11, 2018

DrugPatentWatch Database Preview

Litigation Details for In re: Alfuzosin Hydrochloride Patent Litigation (D. Del. 2008)

« Back to Dashboard

In re: Alfuzosin Hydrochloride Patent Litigation (D. Del. 2008)

Docket ➤ Try a Free Trial Date Filed 2008-06-09
Court District Court, D. Delaware Date Terminated 2010-08-03
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand None Referred To
Parties ACTAVIS SOUTH ATLANTIC LLC; ALFUZOSIN HYDROCHLORIDE PATENT LITIGATION; APOTEX CORP.; APOTEX INC.; AUROBINDO PHARMA LTD.; AUROBINDO PHARMA USA INC.; BARR LABORATORIES INC.; CLERK JEFFERY N. LUTHI; MYLAN PHARMACEUTICALS INC.; PAR PHARMACEUTICAL INC.; RANBAXY INC.; RANBAXY LABORATORIES LIMITED; SANOFI-AVENTIS; SANOFI-AVENTIS US LLC; SUN PHARMA ADVANCED RESEARCH COMPANY LTD.; SUN PHARMA GLOBAL INC.; SUN PHARMACEUTICAL INDUSTRIES INC.; SUN PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS USA INC.; TORRENT PHARMA INC.; TORRENT PHARMACEUTICALS LIMITED; WOCKHARDT LIMITED; WOCKHARDT USA INC.
Patents 4,661,491; 6,149,940
Attorneys Alfred John Saikali; Daniel R. Cherry; David B. Abramowitz; David Ellis Moore; David J. Margules; Eric Cohen; Francis J. Murphy , Jr.; Frederick L. Cottrell , III; George J. Barry , III; Gerald J. Flattmann , Jr.; Ivan M. Poullaos; Jack B. Blumenfeld; James Walter Parrett , Jr.; Jeffrey L. Moyer; Keith D. Parr; Kelly E. Farnan; Kevin M. Nelson; Kurt A. Mathas; Manotti L. Jenkins; Mary Matterer; Philip A. Rovner; Richard L. Horwitz; Scott B. Feder; Sherry L. Rollo; Stephen Jay Bronis; Steven E. Feldman; Thomas J. DeGroot; William T. Vuk
Firms Shook Hardy & Bacon
Link to Docket External link to docket
Small Molecule Drugs cited in In re: Alfuzosin Hydrochloride Patent Litigation
The small molecule drug covered by the patents cited in this case is ➤ Try a Free Trial .

Details for In re: Alfuzosin Hydrochloride Patent Litigation (D. Del. 2008)

Date Filed Document No. Description Snippet Link To Document
2008-06-09 1 Order respect to U.S. Patent Nos. 4,661,491 (the ‘491 patent) and 6,149,940 (the ‘940 patent), which are …Hydrochloride Patent Litigation 9 June 2008 3 August 2010 1:08-md-01941-GMS Patent …LITIGATION IN RE: ALFUZOSIN HYDROCHLORIDE PATENT LITIGATION …Administration’s register of pharmaceutical patents for sanofi’s Uroxatral drug. Centralization under…the parties and the courts. See In re Brimonidine Patent Litigation, 507 F.Supp.2d 1381, 1382 (J.P.M.L. External link to document
2010-05-14 170 infringes the asserted claims of U.S. Patent No. 4,661,491 (the “‘491 patent”). The court held a four-day bench…the ‘491 patent. The court further found that Mylan will induce infringement of the ‘491 patent. 2 The… findings: A. The ‘49l Patent and Procedural Background l. This is a patent infringement action in which…asserted claims of the ‘49l patent. 2. The application that led to the ‘49l patent was filed on May 27, 1986…ght, title, and interest in the ‘49l patent. 4. The ‘49l patent claims a method for treating humans for External link to document
2011-07-07 196 of U.S. Patent No. 4,661,491 (“the ‘491 patent”) and U.S. Patent No. 6,149,940 (“the ‘940 Patent”) in its…Hydrochloride Patent Litigation 9 June 2008 3 August 2010 1:08-md-01941-GMS Patent …ALFUzosIN HYDRoCHLoRiDE MDL NO- 08-md-1941 (GMS) PATENT LITIGATION STIPULATION AND ORDER RE JUDGMENT…"sanofi-aventis") filed an action for patent infringement in this Court against Teva Pharmaceuticals…Multidistrict Litigation, In re Alfi¢zosin Hydrochlorz`de Patent Litigatz`on, MDL No. 08-md-l94l (D. Del.) (the External link to document
2011-07-08 197 (the “asserted claims”) of U.S. Patent No. 4,661,491 (“the ‘491 patent”) against Teva Pharrnaceuticals…the ‘491 patent; 4. that Teva will induce infringement of the asserted claims of the ‘491 patent; 5. that…Hydrochloride Patent Litigation 9 June 2008 3 August 2010 1:08-md-01941-GMS Patent …ALFUZosIN HYDRoCHLoRIDE MDL NO- 08-md-1941 (GMS) PATENT LITIGATION JUDGMENT WITH RESPECT TO TEVA PHARMACEUTICALS…Teva”); 2. that the asserted claims of the ‘491 patent are not invalid; 3. that Teva’s proposed product External link to document
Date Filed Document No. Description Snippet Link To Document

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Mallinckrodt
UBS
Julphar
Teva
Johnson and Johnson
AstraZeneca
Citi
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.